Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy"

Br J Cancer. 2021 Mar;124(6):1177-1178. doi: 10.1038/s41416-020-01214-8. Epub 2020 Dec 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • B7-H1 Antigen
  • Humans
  • Mesothelioma, Malignant*
  • Peritoneal Neoplasms* / drug therapy

Substances

  • B7-H1 Antigen